InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Browse the complete record of transactions filed by NORTHCOTT JOHN, Directeur Commercial. Officer active across 2 companies, notably Nektar Therapeutics. Cumulatively, 11 disclosures have been logged. Total volume traded: €580k. The latest transaction was disclosed on 16 May 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations11 total
€17,3764,592 shares@ €3.78390.0007% mcap3.0% of flow
Common Stock
SEC:0001209191-22-029900:0·
€46,7824,852 shares@ €9.64180.0020% mcap8.1% of flow
Common Stock
SEC:0001209191-22-011437:0·
€46,7824,852 shares@ €9.64180.0020% mcap16.6% of flow
Common Stock
SEC:0001209191-22-011437·
037,800 shares0
Common Stock
SEC:0001209191-21-070691·
037,800 shares0
Common Stock
SEC:0001209191-21-070691:0·
€70,1746,061 shares@ €11.57790.0029% mcap25.0% of flow
Common Stock
SEC:0001209191-21-065221·
€70,1746,061 shares@ €11.57790.0029% mcap12.1% of flow
Common Stock
SEC:0001209191-21-065221:0·
€72,6966,192 shares@ €11.74030.0030% mcap25.8% of flow
Common Stock
SEC:0001209191-21-052385·
€72,6966,192 shares@ €11.74030.0030% mcap12.5% of flow
Common Stock
SEC:0001209191-21-052385:0·
€91,5996,085 shares@ €15.05320.0038% mcap32.6% of flow
Common Stock
SEC:0001209191-21-034186·
€91,5996,085 shares@ €15.05320.0038% mcap15.8% of flow
Common Stock
SEC:0001209191-21-034186:0·
11 of 11 declarations
About NORTHCOTT JOHN
John Northcott is Senior Vice President and Chief Commercial Officer at Nektar Therapeutics. He oversees the company's commercial and marketing efforts, ensuring that products effectively reach the market. His experience in the biopharmaceutical industry is crucial for the organization's success.
